Open the mobile version, with barcode scanning
Class II Terminated

Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% sterile, 3.5 g tube, RX only, Manufactured by Allergan, Irvine, California, 92612, U.S.A., NDC: 0023-0313-0…

Why: Failed Impurities/Degradation Specifications: stability testing results did not meet the specification for impurities.

Company
Allergan Sales, LLC
Waco, TX, United States
Reported
Jul 5, 2017
Recall started
May 1, 2017
Ended
May 1, 2019
Where sold
Nationwide in the US
Amount
648 units
Full product description
Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% sterile, 3.5 g tube, RX only, Manufactured by Allergan, Irvine, California, 92612, U.S.A., NDC: 0023-0313-04.
Lots / codes affected
Lot: 93802, EXP NOV 2019

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.